Cite
MLA Citation
Ian Chau et al.. “Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.” European journal of cancer, vol. 81, 2017, pp. 17–25. http://access.bl.uk/ark:/81055/vdc_100047555881.0x00002f